StockNews.com began coverage on shares of Calithera Biosciences (NASDAQ:CALA – Free Report) in a report published on Saturday morning. The firm issued a hold rating on the biotechnology company’s stock.
Calithera Biosciences Stock Performance
Shares of NASDAQ CALA opened at $0.00 on Friday. Calithera Biosciences has a fifty-two week low of $0.00 and a fifty-two week high of $0.13. The business has a 50 day moving average price of $0.02 and a two-hundred day moving average price of $0.02.
Calithera Biosciences Company Profile
Further Reading
- Five stocks we like better than Calithera Biosciences
- What Are Dividend Champions? How to Invest in the Champions
- Biohaven Stock Soars on Drug Trial Results: Time to Jump In?
- What is the Australian Securities Exchange (ASX)
- Is AMD a Legitimate Threat to NVIDIA? What Investors Should Watch
- Airline Stocks – Top Airline Stocks to Buy Now
- Novo Nordisk’s Setback Won’t Last: A Game-Changing Drug Emerges
Receive News & Ratings for Calithera Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calithera Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
